September 2019 - Page 10 of 24

WednesdaySep 18, 2019 2:11 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Developing Solutions to Meet Major Therapeutic Needs

Endonovo Therapeutics (OTCQB: ENDV) develops, manufactures and distributes innovative medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. An article discussing the company reads, “Dr. Peter Novak, who recently joined Endonovo’s scientific advisory board, said he believes that the company’s noninvasive Electroceutical® Therapy represents ‘a fascinating new frontier.’ Novak is the director of the Autonomic Laboratory at the Department of Neurology, Brigham and Women’s Hospital in Boston, Massachusetts. He is a board-certified neurologist and a board-certified autonomic specialist. . . . ‘Endonovo has assembled a pipeline that…

WednesdaySep 18, 2019 12:32 pm

VIVIS Acquisition to Facilitate Neutra Corp.’s (NTRR) Faster CBD Retail Market Positioning

Strategic acquisitions are an important part of Neutra Corp.’s expansion strategy aimed at securing a better position on the CBD retail market The company has completed its acquisition of VIVIS, an emerging retail brand of hemp-based health and nutritional products Superior quality and third-party certification set VIVIS apart from other market competitors and allow for effortless differentiation On September 10, 2019, Neutra Corp. (OTCQB: NTRR) completed a previously announced acquisition of VIVIS Corp., an emerging retail brand of hemp-based wellness and health products, founded to offer clients high quality, potent hemp-extracted solutions. This area of specialization makes VIVIS a great…

WednesdaySep 18, 2019 12:01 pm

Predictive Oncology Inc. (NASDAQ: POAI) Utilizes Proprietary Dataset to Revolutionize Treatment Outcomes for Cancer

Predictive Oncology is working to develop highly customizable assessment methods to individualize treatment options for cancer, improving outcomes POAI’s innovative technology is pioneering in the field of individualizing treatment for ovarian cancer Predictive Oncology offers potential for significant ROI as it focuses on improving outcomes for cancer patients of today and tomorrow Predictive Oncology Inc. (NASDAQ: POAI) is harnessing its unique, proprietary database of cancer cases using the proven power of artificial intelligence (AI) to revolutionize treatment outcomes for cancer patients. The company works alongside pharmaceutical, diagnostic and biotechnology industry players to develop highly customizable assessment methods that can be…

WednesdaySep 18, 2019 11:33 am

Spectrum Global Solutions Inc. (SGSI) Prepared for Next Generation 5G Communication Services

Spectrum Global Solutions Inc. is a solution and service provider for carriers, aggregators, utilities and enterprise clients The company provides both wireless and wireline services and solutions, with offerings ranging from small and local to extensive and large-scale SGSI is well-positioned to capitalize on the 5G rollout planned for 2019 and beyond Spectrum Global Solutions Inc. (OTCQB: SGSI) provides excellent solutions for next-generation wireless networks through its professional services and installation capabilities for service providers and corporate enterprise markets. Part of the mission of Spectrum Global Solutions is to be the premier world-class industry leader providing the best services possible…

WednesdaySep 18, 2019 11:07 am

Geyser Brands Inc. (TSX.V: GYSR) Announces Upcoming Acquisition, Financial Results and Early 2019 Milestones

Geyser Brands recently announced the TSX Venture Exchange’s conditional approval of its acquisition of Solace Management Group One of Solace Management Group’s most noteworthy assets is Apawthecary Pets – a line of hemp-based pet treats, salves and oral drops available for purchase throughout Canada Geyser also presented its financial results for the eight months ended in March 31, 2019, as well as providing several strategic milestones that will be determining for the growth and stability of the company in the future Global science-led consumer health care company Geyser Brands Inc. (TSX.V: GYSR) recently announced that it was ready to move…

WednesdaySep 18, 2019 10:29 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured on Stock Day with Everett Jolley to Discuss Advancements in Proprietary Platforms

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its President and CEO Richard T. Schumacher was recently featured on The Stock Day Podcast hosted by Everett Jolley. During the interview, Schumacher discussed PBIO and the company’s recent achievements. “A year ago, PBIO had one revenue-generating division. We now have three, each based on our proprietary PCT, BaroFold, or UST platforms,” PBIO President and CEO Richard T. Schumacher said in the podcast. “Our PCT platform supports our primary business, which…

WednesdaySep 18, 2019 10:22 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) CEO to Present Via Webcast at September 19 Singular Research Midwestern Values Conference

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that it will present, via webcast, at the Singular Research Midwestern Values Conference on September 19, 2019. Genprex Chairman and CEO Rodney Varner will lead the company's webcast presentation. The presentation is scheduled to begin at 4:00 PM Central Time, and interested parties may register for the webcast via the Singular Research website. To view the full press release, visit http://ibn.fm/iMR2r About Genprex, Inc. Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial…

WednesdaySep 18, 2019 10:01 am

QualityStocksNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Releases of Q4 and 2019 Fiscal Year End Financial Results

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Tuesday announced the release of its financial and operating results for the fourth quarter and fiscal year ended June 30, 2019. Among the results, the company reported achievement of its first positive Adjusted EBITDA quarter of $3.2 million, a 90% increase in net revenue to $19 million in Q4 2019, up from $10 million in Q3 2019, as well as a 370% increase in fiscal total revenue to $41.8 million in 2019, up from $8.9 million in 2018. “We end fiscal 2019 as one of the few Canadian cannabis businesses…

WednesdaySep 18, 2019 9:28 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Completes Debt Transaction

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in California, this morning announced the completion of the debt transaction previously announced by Plus on September 11 concerning the issuance of units consisting of subordinate voting shares and warrants in exchange for the settlement of certain debt. In accordance with an escrow agreement ancillary to the debt transaction, 50% of the issued shares will be held in escrow until specific conditions detailed in the agreement are met. Per the previous announcement regarding the transaction, all securities issued are subject to a statutory four-month hold period. To view…

TuesdaySep 17, 2019 2:31 pm

QualityStocksNewsBreaks – Organigram Holdings Inc.’s (TSX: OGI) (NASDAQ: OGI) Noteworthy Corporate Governance, Financial Performance Drive Success

Organigram Holdings (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, was recently highlighted in an article by Bloomberg titled, ‘Organigram a Canadian Pot Rarity After Four Profitable Quarters’ (http://ibn.fm/paDcr). An article further discussing the company reads, “Along with the company’s impressive corporate governance comes its equally notable — and consistent — financial performance. This is likely due to its team’s adherence to fiscal discipline, something that can be difficult to find in this industry. Bloomberg noted that, with four quarters of profitability under its belt, Organigram Holdings is ‘an anomaly in the…

Site Search

Company Search

Month: September 2019